Using therapy-induced enrichment of CSCs may, therefore, prove to be an extremely useful method for studying CSCs and provide new clues regarding potential therapeutic targets such as ALDH1A1 for their efficient elimination, which will undoubtedly play an indispensable role in improving NSCLC patients’ survival. Here, ALDH1A1 is linked to non-small cell lung carcinoma.